Digital therapeutics are transitioning from curiosities to valuable additions to the pharmaceutical armamentarium, but they’re still not common in mainstream medicine.
https://www.pharmalive.com/wp-content/uploads/2022/08/DigitalTherapeutics-Biospace.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-08-09 10:12:452022-08-09 10:42:13Digital therapeutics can increase value of disease-modifying drugs
